Abemaciclib
Eli Lilly 
['breast', 'abema', 'increase,(-increased)', 'bcsm', 'abemaciclib']
abemaciclib plus a nonsteroidal aromatase inhibitor led to an increase in the median os in patients with hr+/her2- early breast cancer, both in the itt population and subgroup of patients with visceral disease. #esmo2022 #bcsm | 
Oncology news and insights from leading researchers and cancer centers.